A Genetic Risk Profile in Longitudinal Systemic Lupus Erythematosus (SLE) Cohorts
纵向系统性红斑狼疮 (SLE) 队列的遗传风险概况
基本信息
- 批准号:8249125
- 负责人:
- 金额:$ 34.1万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2011
- 资助国家:美国
- 起止时间:2011-04-01 至 2013-03-31
- 项目状态:已结题
- 来源:
- 关键词:AccountingAddressAdmixtureAfricanAfrican AmericanAmericanAmerindianAutoimmune ProcessBiological MarkersBiostatistics CoreClinicalCollaborationsComplexDevelopmentEnrollmentEnvironmental Risk FactorEthnic OriginEuropeanEvaluationFosteringGenesGeneticGenetic EpistasisGenetic Predisposition to DiseaseGenetic RiskGoalsHispanicsIndividualInstitutionInvestigationJointsKidneyMexicoMorbidity - disease rateNorth AmericaOrganOutcomePatientsPhenotypePopulationPopulation StudyPrevalencePuerto RicoRaceRelative (related person)ResearchRheumatismSeveritiesSiteSystemic Lupus ErythematosusTexasTimeabstractingcohortcost effectivedesignethnic minority populationgenetic epidemiologyhealth disparityindexinginsightmeetingsmortalitynovelprogramstrend
项目摘要
Abstract. The goal of Project 4 is to delineate the complex interactions between genetic ancestry and
environmental factors in the rate of progression and severity of renal involvement and organ damage associated
with systemic lupus erythematosus (SLE). The hypothesis is that SLE patients with a greater percentage of
African or Amerindian ancestry genes both alone and in combination with environmental factors, including low
individual- and group-level SES constructs, have more severe and rapidly progressive SLE as defined by several
longitudinal clinical and soluble biomarker indices. To address this hypothesis, we intend to (1) use panels of
established ancestry informative markers (AIMs) to estimate the extent of individual admixture separately among
European American (EA), African American (AA), Hispanic [from Texas (H-TX), Puerto Rico (H-PR) and Mexico
(H-M)] SLE patients with and without renal involvement and organ damage after controlling for confounding
factors; (2) determine the extent to which the estimates of individual admixture among these groups relate to the
time to indices of renal involvement and organ damage; and (3) determine the extent to which individual- and
group-level SES constructs modify the effect (additive joint effects and epistasis) of individual admixture on the
presence/absence, time to and severity of renal involvement and organ damage among patients with SLE. Using
the expanded PROFILE cohort of current and newly enrolled SLE patients meeting 4 of 11 ACR criteria from the
participating 8 study sites in the continental US, Puerto Rico and Mexico, we intend to exploit targeted
independent and joint contributions of genetic ancestry, using well-characterized AIMs, and environmental (SES)
factors with the tempo of SLE progression. The pooled study population will represent the largest multi-ethnic
population to date of SLE patients, which will allow for a comprehensive evaluation of gene and environmental
influences that are dimorphic by race/ethnicity. This approach offers the best opportunity to rapidly exploit these
relationships and to provide novel insight into the course and outcome of SLE. Results from this longitudinal
investigation will address key questions for understanding the relative contributions of environmental factors and
genetic ancestry that may account for the disparate trends of SLE-related morbidities, severity and progression
that is observed among populations of African and Hispanic ancestries.
Relationship of Project with Overall PPG Priorities. The proposed research plan is designed to examine the
interactions between genetic ancestry markers and environmental factors in the rate of progression and severity
of SLE. This research plan will (1) maximize synergy between all four PPG projects as well as the Administrative
and Genetic Epidemiology and Biostatistics Cores thereby facilitating a rigorous evaluation of our stated specific
aims in a time and cost-effective manner, (2) increase collaboration between partner institutions, (3) foster the
continued development of an effective Rheumatic Diseases Research Program, (4) enhance research efforts
toward SLE-related health disparities and (5) provide novel insight to the genetic etiology of this enigmatic
autoimmune phenotype that is disproportionately more frequent and severe among ethnic minority populations. In
this capacity, this investigation may be used to ultimately narrow the gap in SLE morbidity and mortality that is
disparately observed between African Americans and Hispanic populations.
抽象。项目4的目标是描述遗传祖先和
环境因素影响肾脏受累和相关器官损伤的进展速度和严重程度
系统性红斑狼疮(SLE)这一假设是,SLE患者中,
非洲或美洲印第安人血统基因单独或与环境因素相结合,包括低
个体和组水平的SES结构,具有更严重和快速进展的SLE,如由几个
纵向临床和可溶性生物标志物指数。为了解决这个假设,我们打算(1)使用面板,
建立了祖先信息标记(AIM),以分别估计个体混合的程度,
欧洲裔美国人(EA)、非洲裔美国人(AA)、西班牙裔[来自德克萨斯州(H-TX)、波多黎各(H-PR)和墨西哥]
(H-M)]控制混杂因素后,有和无肾脏受累和器官损害的SLE患者
(2)确定这些组中个体混合物的估计与
至肾脏受累和器官损伤指数的时间;以及(3)确定个体-和
组水平的SES结构修改了个体混合物对
SLE患者中肾脏受累和器官损害的存在/不存在、时间和严重程度。使用
符合11项ACR标准中4项的当前和新入组SLE患者的扩展PROFILE队列,
参与美国大陆、波多黎各和墨西哥的8个研究中心,我们打算利用靶向
独立和共同贡献的遗传祖先,使用良好表征的AIM,和环境(SES)
与SLE进展克里思有关的因素。汇总研究人群将代表最大的多种族
这将允许对SLE患者的基因和环境因素进行全面评估。
影响是由种族/民族的二态性。这种方法提供了最好的机会,快速利用这些
的关系,并提供新的见解SLE的过程和结果。从这个纵向的结果
调查将解决关键问题,以了解环境因素的相对贡献,
可能解释SLE相关发病率、严重程度和进展的不同趋势的遗传祖先
这在非洲人和西班牙人后裔中很常见。
项目与总体PPG优先级的关系。拟议的研究计划旨在研究
遗传祖先标记和环境因素在进展速度和严重程度方面的相互作用
关于SLE该研究计划将(1)最大限度地发挥所有四个PPG项目以及行政管理之间的协同作用,
和遗传流行病学和生物统计学核心,从而促进我们所述的具体的严格评估,
(2)加强伙伴机构之间的合作,(3)促进
继续发展有效的风湿病研究计划,(4)加强研究工作
对SLE相关的健康差异和(5)提供新的见解,这种神秘的遗传病因学
自身免疫表型在少数民族人群中不成比例地更频繁和严重。在
这种能力,这项研究可能被用来最终缩小差距在SLE发病率和死亡率,
在非裔美国人和西班牙裔人群中观察到。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Elizabeth E Brown其他文献
Elizabeth E Brown的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Elizabeth E Brown', 18)}}的其他基金
The UAB-ENhancing Research In Cancer-related Health professions (ENRICH) Program
UAB 增强癌症相关健康专业研究 (ENRICH) 计划
- 批准号:
10627587 - 财政年份:2023
- 资助金额:
$ 34.1万 - 项目类别:
Impact of Genetic susceptibility along the continuum from MGUS to MM
从 MGUS 到 MM 连续体中遗传易感性的影响
- 批准号:
10436093 - 财政年份:2022
- 资助金额:
$ 34.1万 - 项目类别:
Impact of Genetic susceptibility along the continuum from MGUS to MM (Supplement)
从 MGUS 到 MM 连续体中遗传易感性的影响(补充)
- 批准号:
10627525 - 财政年份:2022
- 资助金额:
$ 34.1万 - 项目类别:
Impact of Genetic susceptibility along the continuum from MGUS to MM
从 MGUS 到 MM 连续体中遗传易感性的影响
- 批准号:
10612006 - 财政年份:2022
- 资助金额:
$ 34.1万 - 项目类别:
Epigenetic contribution to the excess risk of MGUS in African Americans
表观遗传对非裔美国人 MGUS 过度风险的影响
- 批准号:
10215787 - 财政年份:2021
- 资助金额:
$ 34.1万 - 项目类别:
Epigenetic contribution to the excess risk of MGUS in African Americans
表观遗传对非裔美国人 MGUS 过度风险的影响
- 批准号:
10405069 - 财政年份:2021
- 资助金额:
$ 34.1万 - 项目类别:
Epigenetic contribution to the excess risk of MGUS in African Americans
表观遗传对非裔美国人 MGUS 过度风险的影响
- 批准号:
10615105 - 财政年份:2021
- 资助金额:
$ 34.1万 - 项目类别:
Characterization of the lupus nephritis microRNAome
狼疮性肾炎 microRNAome 的表征
- 批准号:
10251046 - 财政年份:2018
- 资助金额:
$ 34.1万 - 项目类别:
The Role of Exosome Heparanase and miRNAs as Biomarkers for Myeloma
外泌体乙酰肝素酶和 miRNA 作为骨髓瘤生物标志物的作用
- 批准号:
8771214 - 财政年份:2014
- 资助金额:
$ 34.1万 - 项目类别:
Molecular characterization of myeloma and related asymptomatic precursor states
骨髓瘤的分子特征和相关的无症状前体状态
- 批准号:
8722142 - 财政年份:2014
- 资助金额:
$ 34.1万 - 项目类别:
相似海外基金
Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
- 批准号:
MR/S03398X/2 - 财政年份:2024
- 资助金额:
$ 34.1万 - 项目类别:
Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
- 批准号:
EP/Y001486/1 - 财政年份:2024
- 资助金额:
$ 34.1万 - 项目类别:
Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
- 批准号:
2338423 - 财政年份:2024
- 资助金额:
$ 34.1万 - 项目类别:
Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
- 批准号:
MR/X03657X/1 - 财政年份:2024
- 资助金额:
$ 34.1万 - 项目类别:
Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
- 批准号:
2348066 - 财政年份:2024
- 资助金额:
$ 34.1万 - 项目类别:
Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
- 批准号:
AH/Z505481/1 - 财政年份:2024
- 资助金额:
$ 34.1万 - 项目类别:
Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10107647 - 财政年份:2024
- 资助金额:
$ 34.1万 - 项目类别:
EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
- 批准号:
2341402 - 财政年份:2024
- 资助金额:
$ 34.1万 - 项目类别:
Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10106221 - 财政年份:2024
- 资助金额:
$ 34.1万 - 项目类别:
EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
- 批准号:
AH/Z505341/1 - 财政年份:2024
- 资助金额:
$ 34.1万 - 项目类别:
Research Grant